| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0352383000003056 | 0.06080731 |
| NSC 135880 | Null | 0.0352383000003056 | 0.25186378 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0352383000003056 | 0.12339608 |
| NSC 23925 | Null | 0.0352383000003056 | 0.1462032 |
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0352383000003056 | 0.073717788 |
| NSC 294961 | 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one | 0.0352383000003056 | 0.18886525 |
| NSC 339137 | PHYSALOLACTONE | 0.0352383000003056 | 0.19821476 |
| NSC 354974 | Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- | 0.0352383000003056 | -0.073381062 |
| NSC 371777 | Null | 0.0352383000003056 | 0.14606565 |
| NSC 372155 | 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- | 0.0352383000003056 | 0.14611212 |